Key result
This review discusses minimally invasive technologies, including percutaneous and transcatheter-based devices, as alternatives to traditional surgery for aortic valve disease in elderly patients.
This review summarizes current and emerging minimally invasive transcatheter therapies for aortic valve disease in elderly patients who are poor surgical candidates.
Supports transcatheter options for high-risk elderly aortic valve patients; leaves open optimal device selection and durability questions.
In the aging population of the USA, the burden of aortic valve disease continues to be a major contributor to mortality and morbidity, affecting millions of patients annually. While traditional surgical management has produced excellent results, many elderly patients are not good surgical candidates for invasive procedures. Recently, considerable effort has been placed in developing less invasive approaches that will benefit the elderly. Currently, a wide range of minimally invasive technologies exist at the surgeon’s disposal, including percutaneous and transcatheter-based devices. In this review, we examine the current gold-standard therapies and outcomes, as well as the exciting approaches that are being tested. Finally, we address the future direction in management of aortic valve disease in the elderly and its impact on clinical practice.
No takes yet. Share an insight, caveat, or question.
Comas et al. (2012) conducted a review in Aortic valve disease. Minimally invasive technologies (percutaneous and transcatheter-based devices) vs. Traditional surgical management was evaluated. This review discusses minimally invasive technologies, including percutaneous and transcatheter-based devices, as alternatives to traditional surgery for aortic valve disease in elderly patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: